Press Releases Aspira Women's Health Inc.

Equities

AWH

US04537Y2081

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-02 pm EDT			5-day change	1st Jan Change
3.213 ^USD	-0.21%		-2.04%	-21.25%

May. 02	Aspira Women's Health Inc. Enhances Its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of Ovawatch	CI
Apr. 26	Aspira Women's Health Inc. Announces Minh Merchant Resigns as General Counsel, Chief Compliance Officer, and Corporate Secretary, Effective May 6, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch	May. 02	AQ
Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California	Apr. 09	AQ
Aspira: Q4 Earnings Snapshot	Mar. 28	AQ
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 28	AQ
Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call	Mar. 25	AQ
Aspira Women Health : Management Change/Compensation - Form 8-K	Mar. 25	PU
Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference	Mar. 21	AQ
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President	Mar. 18	AQ
Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024	Mar. 11	AQ
Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference	Feb. 22	AQ
Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)	Feb. 12	AQ
Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines	Feb. 06	AQ
Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement	Jan. 25	AQ
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024	Dec. 19	AQ
Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024	Dec. 14	AQ
Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis	Dec. 06	AQ
Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)	Nov. 28	AQ
Aspira Women’s Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)	Nov. 27	AQ
Aspira: Q3 Earnings Snapshot	Nov. 13	AQ
Aspira Women’s Health Reports Third Quarter 2023 Financial Results	Nov. 13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Aspira Women's Health Inc.

Equities

AWH

US04537Y2081

Press Releases

Filters